外科理论与实践2025，Vol.30Issue(2)：112-119,8.DOI:10.16139/j.1007-9610.2025.02.04
胆道恶性肿瘤免疫相关不良事件的预防与处理
Prevention and management of immune-related adverse events for biliary tract cancers
刘坤 1郭伟1
作者信息
- 1. 首都医科大学附属北京友谊医院普外科,北京 100050
- 折叠
摘要
Abstract
Immune checkpoint inhibitors(ICIs)combined with chemotherapy has become the first-line standard treatment for advanced biliary tract cancers(BTC).However,the application of ICIs comes with its risks of immune-related adverse events(irAEs).BTC patients often face greater challenges in the diagnosis and management of irAEs,especially in the differential diagnosis of immune related hepatitis,due to the presence of special conditions such as underlying liver dysfunction and biliary obstruction.We aimed to systematically review the current status of BTC immunotherapy,the spectrum of irAEs,clinical characteristics,prevention strategies,and management principles.We focused to investigate the specificity and response measures of irAEs management in BTC patients,optimizing immunotherapy management for BTC patients,maximizing treatment benefits and ensuring patient safety,and exploring the future research directions.关键词
胆道恶性肿瘤/免疫治疗/免疫检查点抑制剂/免疫相关不良事件Key words
Biliary tract cancer(BTC)/Immunotherapy/Immune checkpoint inhibitor(ICI)/Immune-related adverse event(irAE)分类
医药卫生引用本文复制引用
刘坤,郭伟..胆道恶性肿瘤免疫相关不良事件的预防与处理[J].外科理论与实践,2025,30(2):112-119,8.
